ArticleFrontiers in pharmacology2025

Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.

Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.